Axcella Health, Inc.

Axcella Health, Inc.

Axcella Health, Inc.

Date Founded



155 Federal Street,Suite 700,Boston, MA 02110

Type of Company


Employees (Worldwide)

11 - 50


Holding Companies
Medical Support Services

Company Description

Axcella Health, Inc. provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology. It creates oral biologics to address health conditions caused or worsened by imbalances in amino acids that lead to harmful changes in cellular homeostasis. The firm's products enhance health by activating specific physiologic events that focus on amino acid imbalances and act to restore cellular homeostasis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn and David A. Berry in 2010 and is headquartered in Cambridge, MA.

Executives & Employees


President & Chief Executive Officer

Senior Vice President of Finance & Chief Financial Officer

Senior Vice President of Research & Development, Chief Scientific Officer

Director, Corporate Development

Senior Vice President, Chief Regulatory Science, Patient Advocacy & Pharmacovigilance Officer

Senior Vice President of Clinical Development, Chief Medical Officer

Senior Vice President, Finance & Operations

Vice President, IP & Legal Affairs

Vice President, Product Development

Board of Directors

Executive Partner at Flagship Pioneering

Professor at Harvard University

Co-Founder at Gurnet Point Capital LLC

Founder at Fate Therapeutics, Inc.

Co-Founder at Indigo Agriculture, Inc.

Faculty Director of the Deshpande Center for Technological Innovation at Massachusetts Institute of Technology

President at ModeRNA Therapeutics, Inc.

President & Chief Executive Officer at Axcella Health, Inc.

President, Chief Executive Officer & Director at Nestlé Health Science SA

Harry E. Figgie, Junior Professor of Business Administration at Harvard University - Harvard Business School

Paths to Axcella Health, Inc.
Potential Connections via
Relationship Science
Axcella Health, Inc.
Advisors & Consultants

Co-Founder at Read Coor, Inc.


Co-Founder at Indigo Agriculture, Inc.

Legal Advisor

National Co-Chair, Life Sciences Practice at Goodwin Procter LLP

Details Hidden
Details Hidden

Flagship Pioneering focuses on investments in the following sectors: (1) therapeutics (2) life science tools and diagnostics and (3) bioenergy and clean technology. The firm looks for companies with exceptional management teams and significant commercial opportunities resulting from market discontinuities or technology breakthroughs. Flagship Ventures typically serves as lead investor. The majority of their investments are seed or first round investments. Initial investments range from $250,000 to $5 million, with typically initial investments ranging from $2.5 million to $4 million. Flagship Ventures may invest up to $15 million to $20 million over the life of a venture and typically forms syndicates that include other venture capital firms